MNKD

MannKind Corporation Healthcare - Biotechnology Investor Relations →

NO
23.3% ABOVE
↓ Approaching Was 23.6% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $4.69
14-Week RSI 53

MannKind Corporation (MNKD) closed at $5.78 as of 2026-02-02, trading 23.3% above its 200-week moving average of $4.69. The stock is currently moving closer to the line, down from 23.6% last week. The 14-week RSI sits at 53, indicating neutral momentum.

Over the past 1075 weeks of data, MNKD has crossed below its 200-week moving average 11 times. On average, these episodes lasted 58 weeks. The average one-year return after crossing below was -5.8%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $1775 million, MNKD is a small-cap stock. The company generates a free cash flow yield of 1.6%. The stock trades at -39.9x book value.

Share count has increased 20.5% over three years, indicating dilution.

Over the past 20.7 years, a hypothetical investment of $100 in MNKD would have grown to $13, compared to $816 for the S&P 500. MNKD has returned -9.3% annualized vs 10.7% for the index, underperforming the broader market over this period.

Free cash flow has been volatile over the past several years, making the quality of earnings harder to assess.

Growth of $100: MNKD vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After MNKD Crosses Below the Line?

Across 11 historical episodes, buying MNKD when it crossed below its 200-week moving average produced an average return of -10.4% after 12 months (median -58.0%), compared to +12.0% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was -39.7% vs +21.9% for the index.

Each line shows $100 invested at the moment MNKD crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

MNKD has crossed below its 200-week MA 11 times with an average 1-year return of +-5.8% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Jul 2005Jan 20062739.6%+94.8%-89.4%
Mar 2007Jan 201014984.9%-64.5%-92.6%
Feb 2010Feb 201018.9%-41.1%-86.8%
Mar 2010Dec 20103843.5%-50.1%-83.9%
Jan 2011May 201312168.5%-51.0%-79.9%
Apr 2015May 2015416.5%-67.7%-72.3%
Jul 2015Sep 202026895.9%-76.9%-73.1%
Nov 2023Nov 202314.6%+114.3%+68.5%
Dec 2023Feb 20241212.1%+89.9%+61.5%
Apr 2025Apr 202510.4%N/A+27.3%
May 2025Aug 20251522.1%N/A+32.3%
Average58+-5.8%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02